封面
市場調查報告書
商品編碼
1373939

肝素市場,按類型、來源、按應用、國家和地區 - 2023-2030年行業分析、市場規模、市場佔有率和預測

Heparin Market, By Type, By Source, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 301 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年肝素市場規模為95.3億美元,2023年至2030年複合CAGR為4.2%。

肝素市場-市場動態

肝素預防和治療血栓的功效推動市場需求

肝素是一種強效抗凝血​​劑,在需要立即預防或溶解血栓的情況下(包括外科手術、心臟干預以及深部靜脈栓塞和肺栓塞等疾病的治療),是一種快速且不可或缺的藥物。肝素在預防和治療方面的廣泛應用,增強了患者的安全並提高了各種醫療場景中的治療效果。其獨特之處在於其適應性和快速適應不斷變化的條件的能力,即使在潛在出血併發症的情況下也能確保患者的健康。

肝素市場-關鍵洞察

根據研究分析師分享的見解,預計2023年至2030年期間,全球肝素市場將呈現約 4.2%的穩定年成長率。

市場的動力可歸因於肝素在預防和治療血栓方面公認的有效性,使其成為醫療實踐的關鍵組成部分。

從細分來看,普通肝素(UFH)在2022年成為主導類別,反映了其龐大的市場佔有率。此外,在來源類別中,豬源肝素在2022年佔據領先地位。

從地區來看,亞太地區成為2022年市場收入的主要貢獻者。推動該地區市場成長的多種因素凸顯了其在全球舞台上的重要性。

肝素市場細分分析:

全球肝素市場根據類型、來源、應用和地區進行細分。在這個市場模式中,類型細分下有幾個主要類別:普通肝素、低分子量肝素(LMWH)和超低分子量肝素(ULMWH)。

在這些類別中,普通肝素(UFH)成為市場的主導力量。 UFH 作為抗凝血劑在各種醫療環境中發揮非常重要的作用,包括外科手術、心臟介入和血栓性疾病的治療。其廣泛使用歸因於它能夠透過預防或治療潛在危險的血栓來確保患者安全。

肝素市場-地理洞察

全球肝素市場的影響力遍及北美、拉丁美洲、歐洲、亞太地區、中東和非洲等不同地區。每個區域進一步細分為積極參與市場活動的國家。

亞太地區是肝素的重要成長中心,受多種因素影響,需求不斷上升。該地區人口老化導致需求激增。此外,心血管疾病、深部靜脈栓塞和其他血栓相關疾病的激增加劇了該地區對肝素的需求。這些動態凸顯了肝素在解決健康問題方面日益重要的意義。

肝素市場-競爭格局:

肝素市場的競爭格局以幾家在行業中具有影響力的知名企業的存在為標誌。Pfizer、Sanofi和Fresenius Kabi等著名製藥巨頭憑藉其廣泛的產品範圍和全球影響力佔據了巨大的市場佔有率。這些主要參與者提供多種肝素配方,以滿足各種醫療應用的要求。此外,市場上還有學名藥製造商的參與,他們努力透過提供具有成本效益的替代品來獲得競爭優勢。

目錄

第1章 肝素市場概述

  • 研究範圍
  • 市場預估年份

第2章 執行摘要

  • 市場摘錄
    • 依類型分類的肝素市場摘錄
    • 依來源分類的肝素市場摘錄
    • 依應用分類的肝素市場摘錄
    • 依國家分類的肝素市場摘錄
    • 依地區分類的肝素市場摘錄
  • 競爭洞察

第3章 肝素主要市場趨勢

  • 肝素市場促進因素
    • 市場促進因素的影響分析
  • 肝素市場限制
    • 市場限制影響分析
  • 肝素市場機會
  • 肝素市場未來趨勢

第4章 肝素產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第5章 肝素市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第6章 肝素市場格局

  • 2022年肝素市佔率分析
  • 按主要製造商分類資料
    • 既有參與者分析
    • 新興參與者分析

第7章 肝素市場 - 依類型

  • 概述
    • 依類型分類的細分市場佔有率分析
    • 普通肝素
    • 低分子肝素(LMWH)
    • 超低分子肝素(ULMWH)

第8章 肝素市場 - 按來源

  • 概述
    • 按來源分類的細分市場佔有率分析

第9章 肝素市場 -依應用

  • 概述
    • 依應用的細分市場佔有率分析
    • 深部靜脈血栓(DVT)
    • 心房顫動和心臟病發作
    • 冠狀動脈疾病
    • 其他應用

第10章 肝素市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美肝素主要製造商
    • 北美市場規模和預測(依國家)
    • 北美市場規模和預測(依類型)
    • 北美市場規模與預測(按來源)
    • 北美市場規模和預測(依應用)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲肝素主要製造商
    • 歐洲市場規模和預測(依國家)
    • 歐洲市場規模與預測(依類型)
    • 歐洲市場規模與預測(按來源)
    • 歐洲市場規模和預測(依應用)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區(APAC)
    • 概述
    • 亞太地區肝素主要製造商
    • 亞太地區市場規模與預測(依國家)
    • 亞太地區市場規模與預測(依類型)
    • 亞太地區市場規模與預測(按來源)
    • 亞太地區市場規模與預測(依應用)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲肝素主要製造商
    • 拉丁美洲市場規模與預測(依國家)
    • 拉丁美洲市場規模與預測(依類型)
    • 拉丁美洲市場規模與預測(按來源)
    • 拉丁美洲市場規模與預測(依應用)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲肝素主要製造商
    • 中東和非洲市場規模及預測(依國家)
    • 中東和非洲市場規模及預測(依類型)
    • 中東和非洲市場規模及預測(按來源)
    • 中東和非洲市場規模及預測(依應用)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第11章 主要供應商分析 - 肝素產業

  • 競爭儀表板
  • 公司簡介
    • Pfizer
    • Sanofi
    • Fresenius Kabi
    • Aspen Pharmacare
    • LEO Pharma
    • Teva Pharmaceuticals
    • Amphastar Pharmaceuticals
    • Baxter International
    • GlaxoSmithKline(GSK)
    • B. Braun Melsungen AG
    • Mylan
    • Sandoz
    • Leo Pharma
    • Pfizer
    • Hikma Pharmaceuticals

第12章 360 度分析師視角

第13章 附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1815

REPORT HIGHLIGHT

Heparin Market size was valued at USD 9,530 Million in 2022, expanding at a CAGR of 4.2 % from 2023 to 2030.

Heparin is a highly efficient anticoagulant employed in the medical field to prevent the formation of blood clots. This versatile substance can be derived from animal tissues or synthetically synthesized. Its mechanism of action involves the inhibition of critical blood clotting factors like thrombin and factor Xa, effectively reducing the risk of dangerous blood clot development. Heparin administration typically involves injections and plays a vital role in various therapeutic scenarios, such as surgical procedures, dialysis, and the management of conditions like deep vein thrombosis. What sets heparin apart is its rapid onset and the ability to reverse its effects, making it a crucial tool in the treatment of thrombotic disorders. Nevertheless, the precise dosage and monitoring are essential to prevent potential bleeding complications, underscoring its significance in modern medical practice.

Heparin Market- Market Dynamics

Heparin's efficacy in preventing and treating blood clots propel market demand

Heparin, a potent anticoagulant, serves as a rapid and indispensable agent in situations demanding immediate clot prevention or dissolution, including surgical procedures, cardiac interventions, and the management of ailments like deep vein thrombosis and pulmonary embolism. The widespread applicability of heparin, spanning both preventive and therapeutic purposes, enhances patient safety and elevates treatment outcomes in various medical scenarios. Its unique feature lies in its adaptability and the ability to swiftly adapt to changing conditions, ensuring patient well-being even in cases of potential bleeding complications.

Heparin Market- Key Insights

According to insights shared by our research analyst, the global Heparin market is poised to exhibit a steady annual growth rate of approximately 4.2% during the projected period from 2023 to 2030.

The market's momentum can be attributed to Heparin's well-established effectiveness in the prevention and treatment of blood clots, making it a pivotal component of medical practice.

In terms of segmentation, Unfractionated Heparin (UFH) emerged as the dominant category in 2022, reflecting its significant market share. Additionally, within the Source category, Porcine-derived Heparin held a leading position in 2022.

Regionally, Asia Pacific emerged as the primary contributor to market revenues in 2022. The diverse factors driving market growth in this region highlight its significance on the global stage.

Heparin Market- Segmentation Analysis:

The global Heparin Market exhibits a segmentation based on Type, Source, Application, and Region. Within this market landscape, we find two primary categories under the Type segment: Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH).

Of these categories, Unfractionated Heparin (UFH) emerges as the dominant force in the market. UFH plays a vital role as an anticoagulant in various medical settings, including surgical procedures, cardiac interventions, and the management of thrombotic disorders. Its widespread use is attributed to its capacity to ensure patient safety by preventing or treating potentially dangerous blood clots.

Heparin Market- Geographical Insights

The global Heparin Market extends its influence across diverse regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Each of these regions is further subdivided into countries that actively engage in market activities.

The Asia-Pacific region stands out as a significant growth hub for Heparin, with escalating demand influenced by various factors. The region's aging demographic contributes to this demand surge. Moreover, an upsurge in cardiovascular diseases, deep vein thrombosis, and other clot-related conditions has fueled the need for Heparin in this region. These dynamics underline the growing significance of Heparin in addressing health concerns.

Heparin Market- Competitive Landscape:

The competitive landscape within the Heparin market is marked by the presence of several notable players who exert influence in the industry. Prominent pharmaceutical giants like Pfizer, Sanofi, and Fresenius Kabi occupy substantial market share due to their extensive range of products and global presence. These major players offer diverse Heparin formulations tailored to cater to the requirements of various medical applications. Additionally, the market sees participation from generic pharmaceutical manufacturers who strive to gain a competitive edge by presenting cost-effective alternatives.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEPARIN MARKET KEY PLAYERS

  • Pfizer
  • Sanofi
  • Fresenius Kabi
  • Aspen Pharmacare
  • LEO Pharma
  • Teva Pharmaceuticals
  • Amphastar Pharmaceuticals
  • Baxter International
  • GlaxoSmithKline (GSK)
  • B. Braun Melsungen AG
  • Mylan
  • Sandoz
  • Leo Pharma
  • Pfizer
  • Hikma Pharmaceuticals

GLOBAL HEPARIN MARKET, BY TYPE

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)

GLOBAL HEPARIN MARKET, BY SOURCE

  • Bovine
  • Porcine

GLOBAL HEPARIN MARKET, BY APPLICATION

  • Deep Vein Thrombosis (DVT)
  • Atrial Fibrillation and Heart Attack
  • Coronery Artery Disease
  • Other Applications

GLOBAL HEPARIN MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Heparin Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Heparin Market Snippet by Type
    • 2.1.2. Heparin Market Snippet by Source
    • 2.1.3. Heparin Market Snippet by Application
    • 2.1.4. Heparin Market Snippet by Country
    • 2.1.5. Heparin Market Snippet by Region
  • 2.2. Competitive Insights

3. Heparin Key Market Trends

  • 3.1. Heparin Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Heparin Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Heparin Market Opportunities
  • 3.4. Heparin Market Future Trends

4. Heparin Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Heparin Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Heparin Market Landscape

  • 6.1. Heparin Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Heparin Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Unfractionated Heparin
    • 7.1.3. Low Molecular Weight Heparin (LMWH)
    • 7.1.4. Ultra-low Molecular Weight Heparin (ULMWH)

8. Heparin Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2022 & 2030 (%)
    • 8.1.2. Bovine
    • 8.1.3. Porcine

9. Heparin Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 9.1.2. Deep Vein Thrombosis (DVT)
    • 9.1.3. Atrial Fibrillation and Heart Attack
    • 9.1.4. Coronery Artery Disease
    • 9.1.5. Other Applications

10. Heparin Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Heparin Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Heparin Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Heparin Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Heparin Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Heparin Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Heparin Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer
    • 11.2.2. Sanofi
    • 11.2.3. Fresenius Kabi
    • 11.2.4. Aspen Pharmacare
    • 11.2.5. LEO Pharma
    • 11.2.6. Teva Pharmaceuticals
    • 11.2.7. Amphastar Pharmaceuticals
    • 11.2.8. Baxter International
    • 11.2.9. GlaxoSmithKline (GSK)
    • 11.2.10. B. Braun Melsungen AG
    • 11.2.11. Mylan
    • 11.2.12. Sandoz
    • 11.2.13. Leo Pharma
    • 11.2.14. Pfizer
    • 11.2.15. Hikma Pharmaceuticals

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Heparin Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Heparin Market, by Type 2018-2030 (USD Million)
  • TABLE Heparin Market: Source Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Source
  • TABLE Global Heparin Market, by Source 2018-2030 (USD Million)
  • TABLE Heparin Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Heparin Market, by Application 2018-2030 (USD Million)
  • TABLE Heparin Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Heparin Market, by Region 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE North America Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Europe Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Asia Pacific Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Latin America Heparin Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Source, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Heparin Market, by Application, 2018-2030 (USD Million)